Day: January 27, 2026

MITCHEL FIELD, N.Y., Jan. 27, 2026 (GLOBE NEWSWIRE) — Frequency Electronics, Inc. (“FEI” or the “Company”) (NASDAQ-FEIM), a leading provider of precision timing and frequency control products for space and terrestrial applications, is pleased to announce the follow-on award of several contracts from a major aerospace company for precision “g” (acceleration) compensated Oven-controlled Quartz Oscillators (OCXO) for ultimate application in US Government software-defined radio systems. These precision oscillators incorporate FEI’s state-of-the-art patented technology for operating in high dynamic environments and generate precise frequencies that are critical to overall performance of the Link 16 system. The contracts are valued at approximately $6m. Follow-on contracts for additional units valued at over $2m are anticipated within...

Boca Raton, FL, Jan. 27, 2026 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage inflammation and immunology company, presents the following letter to investors from David Moss, CEO: Dear Fellow Shareholders, As we reflect on 2025, I want to thank you for your continued support of INmune Bio. This past year marked an important period of execution, discipline, and focus as we advanced our mission to develop innovative therapies that address serious neuroinflammatory and immunologic diseases with high unmet needs. 2025 was a pivotal year for our company, highlighted by compelling clinical learnings from XPro™ in our Phase 2 Alzheimer’s disease trial and significant progress advancing CORDStrom™ in Recessive Dystrophic Epidermolysis Bullosa (RDEB). Our focus on harnessing the innate immune system to...

DULLES, Va., Jan. 27, 2026 (GLOBE NEWSWIRE) — The National Rural Utilities Cooperative Finance Corporation (CFC) will hold an investor conference call and webcast on Friday, Jan. 30, at noon Eastern Time. CFC Chief Executive Officer Andrew Don will provide a business update, and CFC Senior Vice President and Chief Financial Officer Ling Wang will review CFC’s fiscal year 2026 second-quarter financial results. There are two ways to access the event:Live Webcast OptionVisit CFC’s investor Webcasts & Presentations page to join the webcast. Pre-registration is available for the event.Conference Call OptionDomestic: 800-330-6710 | International: 646-769-9200Participant Code: 1080089Callers also can view a PDF of the slide presentation by visiting Webcasts & Presentations page on the day of the call. It will be posted just...

27 JANUARY 2026 NORTHERN 3 VCT PLC ADMISSION OF FURTHER SHARES TO TRADING In conformity with The Public Offers and Admissions to Trading Regulations 2024 issued by the Financial Conduct Authority (the “FCA”), Northern 3 VCT PLC with the legal entity identifier 213800MWOA6W221PI432 (the “Company”) notifies the market that a further 403,442 ordinary shares with a nominal value of 5p each and ISIN GB0031152027 were admitted to trading on the London Stock Exchange’s market for listed securities and to the Official List of the FCA on 27 January 2026. These further shares are fungible with the existing ordinary shares already admitted to trading. Following this admission of shares there are 159,364,444 ordinary shares admitted to trading. This notification covers all admissions up to and including 27 January 2026. Enquiries: Sarah Williams /...

Parties are collaborating in a multi-phase plan to assess Eye-Net’s collision prevention V2X technology to protect both vehicles and vulnerable road users Ness Ziona, Israel, Jan. 27, 2026 (GLOBE NEWSWIRE) — Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in automotive vision solutions, recently announced that its majority-owned subsidiary, Eye-Net Mobile Ltd. (“Eye-Net”), has advanced its strategic collaboration in Japan with SoftBank Corp. (“SoftBank”) to further validate Eye-Net’s vehicle-to-everything (“V2X”) collision prediction and prevention solutions technology. The joint initiative aims to enhance road safety and operational efficiency by enabling seamless, real-time exchange of location information among surrounding road users. This development represents a continued...

Geneva, Switzerland, Jan. 27, 2026 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced that it is redefining vertical integration in the quantum era by building a platform where trust begins, in silicon. Rather than developing quantum solutions in isolated layers of hardware, software, or connectivity, SEALSQ has designed a fully integrated architecture in which cryptographic identity, post-quantum security, and sovereignty are embedded at the hardware level from the outset. This ensures that security and trust are intrinsic properties of the system, not external add-ons. The initiative began with a pilot Quantum Corridor linking three strategic...

Precise MRD™ to transition from research-use-only into a limited clinical launch in March 2026 SALT LAKE CITY, Jan. 27, 2026 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced a commercialization roadmap for its Precise MRD™ (molecular residual disease) assay and highlighted compelling data that reinforces the clinical value of ultrasensitive circulating tumor DNA (ctDNA) detection across cancer types. Myriad will launch Precise MRD with select community-based clinicians in March 2026 in breast, followed by colorectal and renal cancers later this year. The company may expand into additional cancer types, including ovarian and endometrial in 2027 and beyond. “Our Precise MRD program reflects Myriad’s unwavering commitment to advancing...